Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 40 | 33 | 2 | 0 | 2 | 2 | 2 | 45 | 51 | 104 | | 136 |
% Growth | NA | -16.4% | -94.0% | -86.5% | 629.9% | 18.5% | -31.0% | 2704.7% | 12.9% | 105.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (37) | (35) | (4) | (2) | (3) | (3) | (2) | (4) | (3) | (3) | | (30) |
Gross Profit | 3 | (2) | (2) | (1) | (1) | (1) | (1) | 41 | 48 | 101 | | 106 |
% Revenue | 6.5% | -5.9% | -97.4% | -534.8% | -38.5% | -31.0% | -47.9% | 92.1% | 94.9% | 96.7% | | 78.2% |
| | | | | | | | | | | | |
Research and Development | (0) | (0) | (0) | 0 | (0) | 0 | (0) | 0 | 0 | 0 | | 0 |
Selling and Marketing | (1) | (2) | (0) | 0 | (0) | (0) | (0) | 0 | 0 | 0 | | 0 |
General and Admin | (4) | (4) | (1) | (1) | (1) | (2) | (1) | (4) | (5) | (8) | | (13) |
Other Inc / (Exp) | (0) | (2) | (8) | 33 | 3 | 1 | 1 | (36) | (41) | (86) | | (86) |
Total Operating Exp | (5) | (9) | (9) | 32 | 1 | (1) | (0) | (40) | (47) | (94) | | (99) |
| | | | | | | | | | | | |
Operating Income | (3) | (11) | (11) | 30 | 1 | (2) | (1) | 1 | 1 | 6 | | 7 |
% Revenue | -7.3% | -32.2% | -572.5% | 11333.2% | 32.9% | -82.2% | -76.6% | 2.5% | 2.8% | 6.1% | | 5.3% |
| | | | | | | | | | | | |
Interest Expense | (0) | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) | (0) | | (0) |
Pre-tax Income | (3) | (11) | (12) | 30 | 1 | (2) | (1) | 1 | 1 | 6 | | 7 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (1) | (3) | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (2) | | (2) |
Net Income to Company | (4) | (14) | (12) | 30 | 1 | (2) | (1) | 1 | 1 | 4 | | 4 |
% Margin | -9.7% | -42.1% | -594.4% | 11200.2% | 32.5% | -83.6% | -80.8% | 1.2% | 1.6% | 4.0% | | 3.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | (0) | (2) | | (2) |
Net Income to Stockholders | (4) | (14) | (12) | 30 | 1 | (2) | (1) | 1 | 0 | 2 | | 2 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (4) | (14) | (12) | 30 | 1 | (2) | (1) | 1 | 0 | 2 | | 2 |
% Margin | -9.7% | -42.1% | -594.4% | 11200.2% | 32.5% | -83.7% | -79.4% | 1.2% | 0.6% | 2.1% | | 1.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (1.13) | (4.12) | (3.48) | 0.00 | 0.16 | 0.00 | (0.31) | 0.00 | 0.03 | 0.19 | | 0.17 |
Diluted EPS (Continuing Ops) | (1.13) | (4.12) | (3.48) | 0.00 | 0.16 | 0.00 | (0.31) | 0.00 | 0.03 | 0.19 | | 0.17 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 3.40 | 3.40 | 3.40 | 0.00 | 4.08 | 0.00 | 4.08 | 0.00 | 11.49 | 11.49 | | 0.00 |
WA Diluted Shares Out. | 3.40 | 3.40 | 3.40 | 0.00 | 4.08 | 0.00 | 4.08 | 0.00 | 11.49 | 11.49 | | 0.00 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (3) | (11) | (12) | 30 | 1 | (2) | (1) | 1 | 1 | 6 | | 7 |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | 1 | 1 | 0 | (34) | (0) | 0 | 0 | 0 | 0 | (0) | | 0 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 40 | 85 | | 85 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (0) | 0 | (0) | (0) | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | (1) | 0 | 2 | 0 | (4) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 1 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | (3) | (9) | (5) | (3) | (3) | (2) | (0) | 37 | 42 | 91 | | 93 |
% Margin | -6.3% | -25.6% | -253.2% | -1208.2% | -141.9% | -76.4% | -27.0% | 81.9% | 83.4% | 87.5% | | 68.1% |
| | | | | | | | | | | | |
Adjusted EBIT | (3) | (9) | (5) | (3) | (3) | (2) | (1) | 36 | 42 | 91 | | 92 |
% Margin | -7.3% | -26.7% | -262.5% | -1277.7% | -145.7% | -79.5% | -48.1% | 81.2% | 82.7% | 87.4% | | 67.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (4) | (14) | (12) | 30 | 1 | (2) | (1) | 1 | 1 | 4 | | 4 |
Addback: Unusual Items | (1) | 1 | 6 | 0 | (3) | 0 | 0 | 35 | 40 | 85 | | 85 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (0) | (1) | 0 | 1 | (0) | (0) | (9) | (10) | (22) | | (22) |
Adjusted Net Income | (4) | (13) | (8) | 30 | (2) | (2) | (1) | 27 | 31 | 67 | | 67 |
% Margin | -11.1% | -40.6% | -379.9% | 11200.2% | -97.0% | -82.5% | -64.1% | 59.4% | 60.4% | 64.3% | | 49.5% |